Medical information Clinical review pending

Genetic Testing

F9 Gene Thrombophilia Xlinked Due To Factor IX Defect Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the F9 gene, associated with an increased risk of thrombotic disorders like blood clots. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA Card. Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: A clinical history review and genetic counseling session, including a pedigree chart of affected family members, are recommended before the test. Confirm with the laboratory before booking.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the F9 Gene Thrombophilia Xlinked Due To Factor IX Defect Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Family history of thrombophilia or clotting disorders
✓Unexplained blood clots
✓History of recurrent miscarriages
✓Personal or family history of Factor IX deficiency
✓Pre-surgical risk assessment for clotting
✓Evaluation of bleeding or clotting tendencies

In plain language

What this test helps you understand

Identifies genetic mutations in the F9 gene associated with Factor IX deficiency and an increased risk of thrombotic events. Helps in assessing predisposition to blood clotting disorders.

The F9 Gene Thrombophilia Xlinked due to factor IX defect NGS Genetic DNA Test is a diagnostic tool used to identify genetic predispositions to thrombotic disorders linked to the F9 gene. Understanding your genetic risk for thrombophilia is important for managing potential health complications, such as deep vein thrombosis and pulmonary embolism. This test uses Next Generation Sequencing (NGS) technology to detect mutations in the F9 gene, which provides instructions for making factor IX, a protein essential for blood clotting. Identifying these mutations helps healthcare providers assess an individual's risk for developing thrombosis. This test is particularly relevant for individuals with a family history of clotting disorders, those experiencing unexplained blood clots, or individuals with a history of recurrent miscarriages. Early identification allows for proactive management and informed decision-making regarding lifestyle and medical interventions. Discussing the results with your healthcare provider is crucial for understanding their implications and developing appropriate management strategies.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationA clinical history review and genetic counseling session, including a pedigree chart of affected family members, are recommended before the test. Confirm with the laboratory before booking.

SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA Card. Confirm specific requirements with the laboratory before booking.

MethodologyNext Generation Sequencing (NGS) is used to detect mutations within the F9 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the F9 gene. Other genetic or acquired factors can also contribute to thrombophilia. A negative result does not completely rule out the condition. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Thrombophilia is a condition where blood has an increased tendency to form clots. It can be inherited (genetic) or acquired.

The F9 gene provides instructions for making factor IX, a protein crucial for the blood clotting process.

Individuals with a family history of clotting disorders, unexplained clots, or recurrent miscarriages may be candidates. Discuss with your doctor.

A positive result indicates the presence of mutations in the F9 gene, suggesting an increased risk for thrombotic events. Your doctor will discuss the implications.

A negative result means no mutations were detected in the F9 gene. However, other factors can cause thrombophilia, so discuss the result with your doctor.

A blood sample, extracted DNA, or a drop of blood on an FTA card can be used. Specific instructions will be provided upon booking.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp